MAT2A and hepatocellular carcinoma: Collectively, these data indicate that MAT2A ADP ribosylation is frequently downregulated in HCC tumors that is associated with high c-Myc but with low SIRT4 protein level, which may be potential biomarkers for hepatocellular cancer diagnosis.